MAP2K7 and colorectal cancer: Previous studies have shown that CCN1 activates the FAK/MEK/ERK signaling pathway in colorectal cancer by binding to integrin αVβ5 to activate STAT3, a key upstream molecule known to regulate S100A8 [32, 33, 34].